Clin2
NCT07166354Possibly a fitNot yet recruiting

Testing a new treatment for gray hair

CanitiesGrey Hair

Part of Skin clinical trials.

This study tests whether a new drug (CS-001) that targets a protein called mTOR can help reverse or slow gray hair growth. If you are generally healthy, have gray hair, and meet the other requirements, you may be a good fit.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1/Phase 2
Enrollment
100 people
Ages
30 years to 65 years
Study type
Interventional

Who can take part

  • You are between 30 and 65 years old.
  • You have gray hair (diagnosed by a doctor).
  • You are generally healthy and can apply treatment as directed.
  • You are not pregnant, breastfeeding, or planning to become pregnant.
  • You have not had a serious medical event (like a heart attack) in the past 90 days.
  • You have not used prescription creams or taken part in another trial in the past 30 days.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06745336Not yet recruiting· Phase 3
Testing CS-001 for grey hair in adults

This study tests a new treatment called CS-001 for grey hair. It is for adults aged 30 to 65 who are otherwise healthy and want to see if the treatment can help restore hair color.

NCT06998680Recruiting
Chinese herbs for hair loss and gray hair

This trial tests if Chinese herbal treatments can reduce hair loss and reverse gray hair over 6 months. It may help adults who have thinning hair or graying, as long as they haven't dyed or permed their hair recently.

Xiangtan, Hunan
NCT07280676Recruiting
Effect of a Cosmetic Product on Gray Hair

This study tests whether a cosmetic product can change the look of gray hair. It is looking for healthy adults with a moderate amount of natural gray hair.

Minneapolis, Minnesota
NCT06501924Not yet recruiting· Phase 3
Study of two new treatments for hair loss

This study tests two new topical treatments (DA-002 and DA-005) for hair loss in people with pattern baldness. The goal is to see if they can help hair grow back.

NCT06648850Not yet recruiting· Phase 2/Phase 3
Testing a new treatment for temporary hair shedding

This trial tests a new treatment (DA-001) to reduce hair shedding and help hair grow back in people with telogen effluvium—a temporary hair loss condition. The treatment is applied directly to the scalp, and participants will be followed to see how well it works.

NCT07435012Recruiting· Phase 3
Hair loss treatment trial for men ages 18 to 49

This trial tests a new treatment for male pattern baldness (androgenic alopecia). It is for men with a moderate level of hair loss who have not used any hair loss treatments in the last 90 days.

Vancouver, British Columbia

Hear when a new Canities trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.